Taiwan · Delayed Price · Currency is TWD TSH Biopharm Corporation Statistics
Total Valuation
TPEX:8432 has a market cap or net worth of TWD 1.97 billion. The enterprise value is 1.68 billion.
| Market Cap | 1.97B |
| Enterprise Value | 1.68B |
Important Dates
The next estimated earnings date is Monday, August 3, 2026.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
TPEX:8432 has 38.40 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 38.40M |
| Shares Outstanding | 38.40M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 0.72% |
| Float | 15.12M |
Valuation Ratios
The trailing PE ratio is 13.40.
| PE Ratio | 13.40 |
| Forward PE | n/a |
| PS Ratio | 1.48 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.67 |
| P/FCF Ratio | 7.13 |
| P/OCF Ratio | 7.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.96, with an EV/FCF ratio of 6.09.
| EV / Earnings | 11.41 |
| EV / Sales | 1.26 |
| EV / EBITDA | 6.96 |
| EV / EBIT | 7.37 |
| EV / FCF | 6.09 |
Financial Position
The company has a current ratio of 6.44, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.44 |
| Quick Ratio | 3.56 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.06 |
| Interest Coverage | 277.94 |
Financial Efficiency
Return on equity (ROE) is 11.44% and return on invested capital (ROIC) is 18.19%.
| Return on Equity (ROE) | 11.44% |
| Return on Assets (ROA) | 7.40% |
| Return on Invested Capital (ROIC) | 18.19% |
| Return on Capital Employed (ROCE) | 12.98% |
| Weighted Average Cost of Capital (WACC) | 6.02% |
| Revenue Per Employee | 17.57M |
| Profits Per Employee | 1.94M |
| Employee Count | 76 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 4.03 |
Taxes
In the past 12 months, TPEX:8432 has paid 50.69 million in taxes.
| Income Tax | 50.69M |
| Effective Tax Rate | 20.70% |
Stock Price Statistics
The stock price has increased by +4.91% in the last 52 weeks. The beta is 0.33, so TPEX:8432's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +4.91% |
| 50-Day Moving Average | 51.64 |
| 200-Day Moving Average | 52.72 |
| Relative Strength Index (RSI) | 51.56 |
| Average Volume (20 Days) | 36,253 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:8432 had revenue of TWD 1.34 billion and earned 147.56 million in profits. Earnings per share was 3.83.
| Revenue | 1.34B |
| Gross Profit | 686.94M |
| Operating Income | 228.46M |
| Pretax Income | 244.83M |
| Net Income | 147.56M |
| EBITDA | 241.92M |
| EBIT | 228.46M |
| Earnings Per Share (EPS) | 3.83 |
Balance Sheet
The company has 582.27 million in cash and 17.14 million in debt, with a net cash position of 565.13 million or 14.72 per share.
| Cash & Cash Equivalents | 582.27M |
| Total Debt | 17.14M |
| Net Cash | 565.13M |
| Net Cash Per Share | 14.72 |
| Equity (Book Value) | 1.75B |
| Book Value Per Share | 38.10 |
| Working Capital | 1.22B |
Cash Flow
In the last 12 months, operating cash flow was 279.53 million and capital expenditures -3.18 million, giving a free cash flow of 276.34 million.
| Operating Cash Flow | 279.53M |
| Capital Expenditures | -3.18M |
| Depreciation & Amortization | 13.46M |
| Net Borrowing | -12.46M |
| Free Cash Flow | 276.34M |
| FCF Per Share | 7.20 |
Margins
Gross margin is 51.45%, with operating and profit margins of 17.11% and 11.05%.
| Gross Margin | 51.45% |
| Operating Margin | 17.11% |
| Pretax Margin | 18.34% |
| Profit Margin | 11.05% |
| EBITDA Margin | 18.12% |
| EBIT Margin | 17.11% |
| FCF Margin | 20.70% |
Dividends & Yields
This stock pays an annual dividend of 2.61, which amounts to a dividend yield of 5.09%.
| Dividend Per Share | 2.61 |
| Dividend Yield | 5.09% |
| Dividend Growth (YoY) | 65.63% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 55.17% |
| Buyback Yield | -0.22% |
| Shareholder Yield | 4.87% |
| Earnings Yield | 7.49% |
| FCF Yield | 14.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |